Select Medical Holdings Corp. (SEM)
NYSE · Healthcare
Select Medical Holdings Corp. EBITDA 2016–2025
Select Medical Holdings Corp. annual/quarterly ebitda history and growth rate from 2016 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Select Medical Holdings Corp. ebitda for the quarter ending March 31, 2026 was 136.1 M, a 7.77% decrease year-over-year.
- Select Medical Holdings Corp. ebitda for the twelve months ending March 31, 2026 was 516.5 M, a 32.74% decrease year-over-year.
- Select Medical Holdings Corp. annual ebitda for 2025 was 476.5 M, a 0.90% increase from 2024.
- Select Medical Holdings Corp. annual ebitda for 2024 was 472.2 M, a 0.79% decrease from 2023.
- Select Medical Holdings Corp. annual ebitda for 2023 was 476.0 M, a 35.77% increase from 2022.
- Select Medical Holdings Corp. annual ebitda for 2022 was 350.6 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Select Medical Holdings Corp. EBITDA — FAQ
Select Medical Holdings Corp. (SEM) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SEM's ebitda history?
The chart and table above show Select Medical Holdings Corp.'s ebitda by year and by quarter, including the growth rate.